Cascadian Therapeutics Inc's Hold recommendation is a result of a proprietary process of evaluation and produced conclusions that were above average in 2 areas: an economic sector rated above average in attractiveness, and a mathematical computation of risk/reward that is better than average; and produced below average results in 4 areas: an industry group rated below average in attractiveness, a ranking in the company's sector that is in the middle third, ranking in its industry group that is in the middle third-below average, and analytical scoring that is below average.
AES Corp's Hold recommendation is a result of a process of analysis that is proprietary and produced conclusions that were below average results in 4 areas: a ranking in the company's sector that is in the bottom quarter, ranking in its industry group that is in the bottom quarter, analytical scores that are below average, and a mathematical computation of risk/reward that is average; and produced above average in 2 areas: an economic sector rated above average in attractiveness, and an industry group ranked above average in attractiveness.